Lv7
5000 积分 2023-03-18 加入
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities
1个月前
已完结
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities
1个月前
已关闭
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities
1个月前
已关闭
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities
1个月前
已关闭
Cancer therapy with antibodies
1个月前
已完结
Efficacy of Bispecific Antibody Targeting EpCAM and CD3 for Immunotherapy in Ovarian Cancer Ascites: An Experimental Study
1个月前
已完结
Synaptic degeneration in Alzheimer disease
2个月前
已完结
Tau-targeting therapies for Alzheimer disease: current status and future directions
2个月前
已完结
Synergistic association of Aβ and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults
2个月前
已完结
Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 Gatipotuzumab (GAT) with the anti-EGFR Tomuzotuximab (TO) or Panitumumab in patients with refractory solid tumors
3个月前
已完结
皖公网安备34019202002308
